This announcement is a separate document:
北京市金杜（广州）律师事务所关于大参林医药集团股份有限公司2024年第四次临时股东大会的法律意见书
Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Dashenlin Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated